Innoviva (INVA) 10-Q2022 Q1 Quarterly report

Filed: 5 May 22, 4:03pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. junior Avg

New words: accumulated, acquisition, aid, anniversary, assessed, asset, atrial, bear, bifurcation, breakthrough, Burlingame, California, call, called, calling, candidate, cap, capped, Carlo, case, cell, CHF, committee, concurrently, conform, consecutive, constitute, corrected, correction, counterparty, covenant, cover, customary, decided, deducting, deduction, default, deficit, deploying, developmental, dissolved, drug, earlier, earliest, episode, EPS, equivalent, essential, event, excluding, external, extinguishment, face, facility, FDA, fee, feet, fibrillation, flecainide, forma, forward, frequently, full, fully, fundamental, Gate, goodwill, greater, hedge, higher, immaterial, implementation, implied, inclusive, incorrectly, incremental, indefinite, indenture, InRhythmTM, instrument, intangible, integrated, investor, joint, judgement, laboratory, lag, lead, lesser, leveraging, life, line, mature, maturity, maximum, member, merger, Monte, mutually, Nanolive, negotiated, neurologic, occur, occurred, occurrence, occurring, offer, offering, open, opening, paroxysmal, payment, percent, platform, portion, preceding, preliminary, previously, pro, promissory, property, proportion, psychiatric, qualitative, quantitative, reclassified, recognition, redeemable, redeemed, redemption, reimbursed, rendered, renewal, restated, restriction, retired, retrospective, SA, sale, set, settlement, shadow, similarly, simulation, single, SPAC, space, square, standard, steering, stockholder, strike, Subsequent, subsequently, tested, testing, therapeutic, therapy, Trustee, unamortized, undergo, underwritten, undiscounted, unpaid, unsecured, Waltham, warrant, weighted

Removed: addressed, advancement, aerosolized, alleged, alleging, arbitrator, argument, augmenting, authority, award, awarded, breach, breached, broad, challenging, Chancery, clarify, codified, Complaint, conclusively, confirm, confirmed, consistently, Court, credit, decision, declaration, Delaware, deliver, delivery, determination, directed, dismissal, dispute, distribute, enhance, ensuring, enter, established, evaluating, expand, explore, fiduciary, Finally, formulation, found, generate, guidance, heard, hearing, hydroxychloroquine, indemnification, initiated, injunction, injunctive, interfering, lawsuit, manager, obtain, obtained, oral, order, owner, permanent, prescribed, preventing, pronouncement, provision, pursuing, pursuit, reinvestment, reiterating, relating, relief, requiring, reserve, ruled, seeking, Simplifying, situation, specifically, state, stipulated, substantially, technical, treat, Verified, withholding

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

INVA similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Pavel Raifeld, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of Innoviva, Inc. on Form 10-Q for the period ended March 31, 2022 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended and that information contained in such Quarterly Report on Form 10-Q fairly presents in all material respects the financial condition of Innoviva, Inc. at the end of the periods covered by such Quarterly Report on Form 10-Q and results of operations of Innoviva, Inc. for the periods covered by such Quarterly Report on Form 10-Q.



Date:	May 05, 2022	By:	/s/ Pavel Raifeld
			Pavel Raifeld
			Chief Executive Officer
			(Principal Executive Officer)

CERTIFICATION OF

PRINCIPAL FINANCIAL OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Marianne Zhen, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of Innoviva, Inc. on Form 10-Q for the period ended March 31, 2022 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended and that information contained in such Quarterly Report on Form 10-Q fairly presents in all material respects the financial condition of Innoviva, Inc. at the end of the periods covered by such Quarterly Report on Form 10-Q and results of operations of Innoviva, Inc. for the periods covered by such Quarterly Report on Form 10-Q.



Date:	May 05, 2022	By:	/s/ Marianne Zhen
			Marianne Zhen
			Chief Accounting Officer
			(Principal Financial Officer)

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.